Stabilizing and Protecting Solutions

SPS® Formulation Platform

  • SPS® meet current and emerging needs of our partners in the fields of proteins, biologics, biosimilars, and vaccines as well as drug delivery systems and medical devices or combinations thereof

Our proprietary Stabilizing and Protecting Solutions (SPS®) platform provides next generation formulation technologies to increase stability and protection of therapeutic proteins in dry and liquid formulations

Back

Stabilizing and Protecting solutions platform

Biologics & Biosimilars Platform

MORE INFORMATION

Features

  • possibility of unrefrigerated distribution and storage, e.g. during use by patients
  • appropriate or prolonged shelf life
  • suitable for dry and liquid formulations of biologics incl. high concentration formulations

Benefits

  • maintains efficacy and safety during storage
  • reduces storage and shipping costs
  • provides LCM planning opportunities
  • extends patent lifespan
  • increases competitive advantage
  • increases sales

Vaccines &        Viral Vectors Platform

More Information

Features

  • biosafety level 2
  • thermal stabilization of vaccines
  • possibility of liquid instead of lyophilized formulations
  • possibility to avoid gelatine or albumin
  • strong expertise in the stabilization of viral vectors, e.g. adenoviruses, etc.

Benefits

  • reduces manufacturing costs for products in liquid formulations
  • more possibilities to store viral   vector-based products
  • extends patent lifespan
  • increases competitive advantage

STERILIZATION & BIOFUNCTIONALIZED DEVICES PLATFORM

More Information

Features

  • enables terminal sterilization of biopharmaceuticals & biofunctionalized devices
  • development of biofunctionalized devices from bench to bedside

 

 

Benefits

  • reduces need for aseptic production
  • cost-effective manufacturing
  • innovative medical devices by introducing biological functionality